Lung Diseases, Obstructive  >>  Alvesco (ciclesonide)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center
NCT00404547: Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The ACCEPT-study (BY9010/CA-102)

Completed
4
1121
Canada
Ciclesonide, Usual Care Inhaled Glucocorticosteroids
AstraZeneca
Asthma
04/08
12/08
NCT00826969: Ciclesonide for the Treatment of Airway Hyperresponsiveness

Completed
4
64
Europe
Ciclesonide, Placebo
AstraZeneca
Asthma
07/10
10/11
NCT00395239: Asthma/Steroid Withdrawal Study

Terminated
4
6
Canada
inhaled corticosteroid, Flovent; Pulmicort; Alvesco.
University of Alberta, GlaxoSmithKline
Asthma
10/15
10/15

Download Options